![Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram](https://www.researchgate.net/publication/24213426/figure/fig1/AS:460229222637571@1486738605171/Survival-curves-for-patients-with-CA-15-3-30-kU-l-and-no-metastasis-at-diagnosis-M2-as.png)
Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![Diagnostic accuracy of raised CA 15-3 and CEA tumour marker velocity... | Download Scientific Diagram Diagnostic accuracy of raised CA 15-3 and CEA tumour marker velocity... | Download Scientific Diagram](https://www.researchgate.net/publication/341513518/figure/tbl2/AS:893260222443520@1589981241230/Diagnostic-accuracy-of-raised-CA-15-3-and-CEA-tumour-marker-velocity-for-cancer-recurrence_Q320.jpg)
Diagnostic accuracy of raised CA 15-3 and CEA tumour marker velocity... | Download Scientific Diagram
![Markery nowotworowe: normy, rodzaje, badania i wyniki. Kiedy wykonuje się badanie markerów nowotworowych i co może ono wykazać? | Strona Zdrowia Markery nowotworowe: normy, rodzaje, badania i wyniki. Kiedy wykonuje się badanie markerów nowotworowych i co może ono wykazać? | Strona Zdrowia](https://d-art.ppstatic.pl/kadry/k/r/1/5a/68/5e42c296c848d_o_large.jpg)
Markery nowotworowe: normy, rodzaje, badania i wyniki. Kiedy wykonuje się badanie markerów nowotworowych i co może ono wykazać? | Strona Zdrowia
![Markery nowotworowe – badanie, normy. Co należy zrobić, kiedy wyniki markerów nowotworowych są podwyższone? - portal DOZ.pl Markery nowotworowe – badanie, normy. Co należy zrobić, kiedy wyniki markerów nowotworowych są podwyższone? - portal DOZ.pl](https://azcdn.doz.pl/image/d/article/d058267e-scalecrop-840x350.jpg)
Markery nowotworowe – badanie, normy. Co należy zrobić, kiedy wyniki markerów nowotworowych są podwyższone? - portal DOZ.pl
![PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bc6b05499723112efa11b692439ea1e9164a0fa/3-Table2-1.png)
PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar
![CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram](https://www.researchgate.net/publication/318847012/figure/fig2/AS:631650916511761@1527608722402/CA15-3-tumor-marker-level-over-the-course-of-the-patients-treatment-Solid-line-CA15-3.png)
CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram
![Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009898115003265-t2.jpg)
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr2.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![CLO20-029: The Prognostic and Predictive Significance of Joint İnvestigation of Tumor Marker CA 15-3 and Vitamin D in Breast Cancer Patients in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3.5 (2020) CLO20-029: The Prognostic and Predictive Significance of Joint İnvestigation of Tumor Marker CA 15-3 and Vitamin D in Breast Cancer Patients in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3.5 (2020)](https://jnccn.org/view/journals/jnccn/18/3.5/full-jnccn20197391t1.jpg)
CLO20-029: The Prognostic and Predictive Significance of Joint İnvestigation of Tumor Marker CA 15-3 and Vitamin D in Breast Cancer Patients in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3.5 (2020)
![Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer](https://www.spandidos-publications.com/article_images/ol/16/4/ol-16-04-4679-g01.jpg)
Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer
![Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4244574818b6181db84800ea19173a80fa71094b/2-TableII-1.png)